Journal of Antimicrobial Chemotherapy, 0305-7453

Journal

Publications

  1. Published

    gyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong

    Laura Piddock, May 1996, In: Journal of Antimicrobial Chemotherapy. 37, 5, p. 1032-4 3 p.

    Research output: Contribution to journalArticlepeer-review

  2. Published

    blaNDM-21, a new variant of blaNDM in an Escherichia coli clinical isolate carrying blaCTX-M-55 and rmtB

    Alan McNally, Sep 2018, In: Journal of Antimicrobial Chemotherapy. 73, 9, p. 2336-2339 4 p.

    Research output: Contribution to journalArticlepeer-review

  3. Published
  4. Published
  5. Published

    Waste water effluent contributes to the dissemination of CTX-M-15 in the natural environment

    Peter Hawkey, 1 Jul 2014, In: Journal of Antimicrobial Chemotherapy. 69, 7, p. 1785-1791

    Research output: Contribution to journalArticlepeer-review

  6. Published

    Using HIV resistance tests in clinical practice.

    Stephen Taylor, 1 Aug 2009, In: Journal of Antimicrobial Chemotherapy. 64, 2, p. 218-22 5 p.

    Research output: Contribution to journalReview article

  7. Published

    Triclosan resistance in Salmonella enterica serovar Typhimurium

    Mark Webber & Laura Piddock, 1 Apr 2008, In: Journal of Antimicrobial Chemotherapy. 62, 1, p. 83-91 9 p.

    Research output: Contribution to journalArticle

  8. Published
  9. Published
  10. Published
  11. Published
  12. Published
  13. Published

    The urgent need for new antibacterial agents

    Laura Piddock, Sep 2011, In: Journal of Antimicrobial Chemotherapy. 66, 9, p. 1939-40 2 p.

    Research output: Contribution to journalArticlepeer-review

  14. Published
  15. Published
  16. Published

    The killing action of fleroxacin upon Bacteroides fragilis

    Deborah Griggs, Laura Piddock, Jan 1989, In: Journal of Antimicrobial Chemotherapy. 23, 1, p. 53-8 6 p.

    Research output: Contribution to journalArticlepeer-review

  17. Published

    The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents

    Laura Piddock, Feb 1985, In: Journal of Antimicrobial Chemotherapy. 15, 2, p. 193-200 8 p.

    Research output: Contribution to journalArticlepeer-review

  18. Published

    The importance of efflux pumps in bacterial antibiotic resistance

    Mark Webber & Laura Piddock, 1 Jan 2003, In: Journal of Antimicrobial Chemotherapy. 51, p. 9-11 3 p.

    Research output: Contribution to journalArticle

  19. Published

    The growing burden of antimicrobial resistance

    Peter Hawkey, 1 Sep 2008, In: Journal of Antimicrobial Chemotherapy. 62 Suppl 1, p. i1-9

    Research output: Contribution to journalArticle

  20. Published

    The effect of mutations in the SOS response on the kinetics of quinolone killing

    Laura Piddock, Dec 1989, In: Journal of Antimicrobial Chemotherapy. 24, 6, p. 863-73 11 p.

    Research output: Contribution to journalArticlepeer-review

  21. Published
  22. Published

    The effect of altered porin expression in Escherichia coli upon susceptibility to 4-quinolones

    Laura Piddock, Oct 1986, In: Journal of Antimicrobial Chemotherapy. 18, 4, p. 547-9 3 p.

    Research output: Contribution to journalArticlepeer-review

  23. Published

    The control of class I beta-lactamase expression in Enterobacteriaceae and Pseudomonas aeruginosa

    Julia Lodge & Laura Piddock, Aug 1991, In: Journal of Antimicrobial Chemotherapy. 28, 2, p. 167-72 6 p.

    Research output: Contribution to journalArticlepeer-review

  24. Published

    The antimicrobial activity of cefpirome, a new cephalosporin

    Laura Piddock, Apr 1985, In: Journal of Antimicrobial Chemotherapy. 15, 4, p. 449-56 8 p.

    Research output: Contribution to journalArticlepeer-review

  25. Published

    The accumulation of five quinolone antibacterial agents by Escherichia coli

    Laura Piddock, Mar 1990, In: Journal of Antimicrobial Chemotherapy. 25, 3, p. 319-33 15 p.

    Research output: Contribution to journalArticlepeer-review

  26. Published

    The accumulation of five antibacterial agents in porin-deficient mutants of Escherichia coli

    Laura Piddock, Aug 1993, In: Journal of Antimicrobial Chemotherapy. 32, 2, p. 195-213 19 p.

    Research output: Contribution to journalArticlepeer-review

  27. Published
  28. Published

    The PBPs of Bacteroides fragilis

    Laura Piddock, Sep 1983, In: Journal of Antimicrobial Chemotherapy. 12, 3, p. 292

    Research output: Contribution to journalArticlepeer-review

  29. Published
  30. Published

    The 2017 Garrod Lecture: genes, guts and globalization

    Peter Hawkey, 1 Oct 2018, In: Journal of Antimicrobial Chemotherapy. 73, 10, p. 2589–2600 12 p.

    Research output: Contribution to journalSpecial issuepeer-review

  31. Published

    Teixobactin, the first of a new class of antibiotics discovered by iChip technology?

    Laura Piddock, Oct 2015, In: Journal of Antimicrobial Chemotherapy. 70, 10, p. 2679-80 2 p.

    Research output: Contribution to journalArticlepeer-review

  32. E-pub ahead of print
  33. Published
  34. Published

    Surveillance of HIV antiretrviral drug resistance in treated individuals in England

    Paul Scott, Pat Cane, 12 Feb 2004, In: Journal of Antimicrobial Chemotherapy. 53, p. 469-473 5 p.

    Research output: Contribution to journalArticle

  35. Published

    Should quinolones be used in the treatment of bacterial infections in neutropenic patients?

    Laura Piddock, Nov 1993, In: Journal of Antimicrobial Chemotherapy. 32, 5, p. 771-4 4 p.

    Research output: Contribution to journalArticlepeer-review

  36. Published

    Selection of quinolone-resistant mutants of Haemophilus influenzae and Streptococcus pneumoniae

    Laura Piddock, Jul 1992, In: Journal of Antimicrobial Chemotherapy. 30, 1, p. 109-10 2 p.

    Research output: Contribution to journalArticlepeer-review

  37. Published
  38. Published

    Selection of moxifloxacin-resistant Staphylococcus aureus compared with five other fluoroquinolones

    Deborah Griggs & Laura Piddock, 1 Jun 2003, In: Journal of Antimicrobial Chemotherapy. 51, 6, p. 1403-7 5 p.

    Research output: Contribution to journalArticlepeer-review

  39. Published

    Selection and characterization of cefepime-resistant gram-negative bacteria

    Laura Piddock & Deborah Griggs, Nov 1991, In: Journal of Antimicrobial Chemotherapy. 28, 5, p. 669-76 8 p.

    Research output: Contribution to journalArticlepeer-review

  40. Published
  41. Published

    Role of bacterial efflux pumps in biofilm formation

    1 Aug 2018, In: Journal of Antimicrobial Chemotherapy. 73, 8, p. 2003-2020 18 p.

    Research output: Contribution to journalReview articlepeer-review

  42. E-pub ahead of print
  43. Published

    Regulatory opportunities to encourage technology solutions to antibacterial drug resistance

    Laura Piddock, Sep 2011, In: Journal of Antimicrobial Chemotherapy. 66, 9, p. 1945-7 3 p.

    Research output: Contribution to journalArticlepeer-review

  44. Published
  45. Published
  46. Published
  47. Published

    Quinolone-resistant gyrase mutants demonstrate decreased susceptibility to triclosan

    Mark Webber, Michelle MC Buckner & Laura Piddock, 1 Oct 2017, In: Journal of Antimicrobial Chemotherapy. 72, 10, p. 2755-2763 9 p.

    Research output: Contribution to journalArticlepeer-review

  48. Published

    Quinolone resistance in veterinary isolates of Salmonella

    Deborah Griggs & Laura Piddock, Jun 1994, In: Journal of Antimicrobial Chemotherapy. 33, 6, p. 1173-89 17 p.

    Research output: Contribution to journalArticlepeer-review

  49. Published

    Quinolone resistance and Campylobacter spp

    Laura Piddock, Dec 1995, In: Journal of Antimicrobial Chemotherapy. 36, 6, p. 891-8 8 p.

    Research output: Contribution to journalArticlepeer-review

  50. Published

    Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli

    Laura Piddock, Vito Ricci, Jan 1999, In: Journal of Antimicrobial Chemotherapy. 43, 1, p. 61-70 10 p.

    Research output: Contribution to journalArticlepeer-review

  51. Published
  52. Published
  53. Published
  54. E-pub ahead of print
  55. Published
  56. Published
  57. Published

    Pre-clinical experience with daptomycin.

    Peter Hawkey, 1 Nov 2008, In: Journal of Antimicrobial Chemotherapy. 62 Suppl 3, p. iii7-14

    Research output: Contribution to journalArticle

  58. Published

    Post-therapy multiply resistant mutant of Pseduomonas aeruginosa

    Laura Piddock, 1 Jan 2002, In: Journal of Antimicrobial Chemotherapy. 49, 1, p. 215 1 p.

    Research output: Contribution to journalArticle

  59. Published

    Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis

    Laura Piddock, Sep 2003, In: Journal of Antimicrobial Chemotherapy. 52, 3, p. 481-4 4 p.

    Research output: Contribution to journalArticlepeer-review

  60. Published
  61. Published
  62. Published
  63. Published
  64. Published
  65. Published
  66. Published
  67. Published

    Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection

    David Adams & Alan Ball, Sep 1985, In: Journal of Antimicrobial Chemotherapy. 16, 3, p. 359-66 8 p.

    Research output: Contribution to journalArticlepeer-review

  68. Published
  69. Published
  70. E-pub ahead of print

    Occurrence of colistin-resistant hypervirulent Klebsiella variicola

    Alan McNally, 27 Jul 2018, In: Journal of Antimicrobial Chemotherapy.

    Research output: Contribution to journalArticlepeer-review

  71. Published
  72. Published
  73. Published

    Non-gyrA-mediated ciprofloxacin resistance in laboratory mutants of Streptococcus pneumoniae

    Laura Piddock, May 1997, In: Journal of Antimicrobial Chemotherapy. 39, 5, p. 609-15 7 p.

    Research output: Contribution to journalArticlepeer-review

  74. Published

    Newer mechanisms of resistance to beta-lactam antibiotics in gram-negative bacteria

    Laura Piddock, Sep 1985, In: Journal of Antimicrobial Chemotherapy. 16, 3, p. 279-84 6 p.

    Research output: Contribution to journalArticlepeer-review

  75. Published
  76. Published
  77. E-pub ahead of print
  78. Published

    Mechanisms of resistance to quinolones and clinical perspectives

    Laura Piddock, Apr 1989, In: Journal of Antimicrobial Chemotherapy. 23, 4, p. 475-80 6 p.

    Research output: Contribution to journalArticlepeer-review

  79. Published

    Mechanisms of quinolone action and microbial response

    Peter Hawkey, 1 May 2003, In: Journal of Antimicrobial Chemotherapy. 51, 90001, p. 29-35 7 p.

    Research output: Contribution to journalReview article

  80. Published

    Mechanism of quinolone uptake into bacterial cells

    Laura Piddock, Apr 1991, In: Journal of Antimicrobial Chemotherapy. 27, 4, p. 399-403 5 p.

    Research output: Contribution to journalArticlepeer-review

  81. Published
  82. Published
  83. Published

    Interaction of divalent cations, quinolones and bacteria

    Laura Piddock, Oct 1994, In: Journal of Antimicrobial Chemotherapy. 34, 4, p. 465-83 19 p.

    Research output: Contribution to journalArticlepeer-review

  84. Published

    Inhibition of multidrug efflux as a strategy to prevent biofilm formation

    Laura Piddock & Mark Webber, Mar 2014, In: Journal of Antimicrobial Chemotherapy. 69, 3, p. 673-681 9 p.

    Research output: Contribution to journalArticlepeer-review

  85. Published

    Induction of beta-lactamases in gram-negative bacilli

    Laura Piddock, Nov 1987, In: Journal of Antimicrobial Chemotherapy. 20, 5, p. 767-8 2 p.

    Research output: Contribution to journalArticlepeer-review

  86. Published
  87. Published
  88. E-pub ahead of print
  89. Published

    In-vitro activity of quinolones and macrolides against mycobacteria

    Laura Piddock, Sep 1994, In: Journal of Antimicrobial Chemotherapy. 34, 3, p. 343-51 9 p.

    Research output: Contribution to journalArticlepeer-review

  90. Published
  91. Published
  92. Published
  93. E-pub ahead of print
  94. Published

    High-level quinolone resistance in Pseudomonas aeruginosa

    Laura Piddock & Peter Hawkey, Aug 1992, In: Journal of Antimicrobial Chemotherapy. 30, 2, p. 229-31 3 p.

    Research output: Contribution to journalArticlepeer-review

  95. Published
  96. Published
  97. Published
  98. Published

    Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype

    Peter Hawkey, 1 Aug 2017, In: Journal of Antimicrobial Chemotherapy. 72, 8, p. 2145-2155 11 p.

    Research output: Contribution to journalReview articlepeer-review

  99. Published
  100. Published
Previous 1 2 Next